Geneva Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.8M Sell
103,634
-5,417
-5% -$1.16M 0.5% 57
2026
Q1
$24.1M Buy
109,051
+4,886
+5% +$1.2M 0.51% 59
2025
Q4
$26.4M Buy
104,165
+1,821
+2% +$457K 0.5% 61
2025
Q3
$25.3M Sell
102,344
-4,997
-5% -$1.2M 0.43% 67
2025
Q2
$25.8M Buy
107,341
+3,516
+3% +$819K 0.43% 70
2025
Q1
$23.5M Sell
103,825
-2,150
-2% -$473K 0.44% 68
2024
Q4
$21.8M Sell
105,975
-13,842
-12% -$3.04M 0.38% 76
2024
Q3
$29.1M Sell
119,817
-3,201
-3% -$749K 0.49% 67
2024
Q2
$27M Sell
123,018
-10,239
-8% -$2.22M 0.49% 68
2024
Q1
$30M Sell
133,257
-2,535
-2% -$572K 0.53% 63
2023
Q4
$29.9M Sell
135,792
-4,732
-3% -$1M 0.56% 63
2023
Q3
$30.8M Sell
140,524
-4,879
-3% -$1.1M 0.65% 53
2023
Q2
$32.7M Buy
145,403
+4,448
+3% +$890K 0.65% 57
2023
Q1
$27M Buy
140,955
+1,267
+0.9% +$245K 0.55% 66
2022
Q4
$25.8M Buy
139,688
+2,590
+2% +$455K 0.58% 64
2022
Q3
$22.8M Sell
137,098
-3,173
-2% -$646K 0.53% 69
2022
Q2
$28.9M Sell
140,271
-2,415
-2% -$545K 0.67% 59
2022
Q1
$34.5M Sell
142,686
-7,412
-5% -$1.72M 0.67% 59
2021
Q4
$36.5M Sell
150,098
-5,233
-3% -$1.2M 0.59% 70
2021
Q3
$31.7M Sell
155,331
-8,992
-5% -$1.92M 0.54% 77
2021
Q2
$33.9M Sell
164,323
-8,120
-5% -$1.63M 0.55% 75
2021
Q1
$32.8M Sell
172,443
-9,324
-5% -$1.73M 0.56% 76
2020
Q4
$34.5M Sell
181,767
-22,665
-11% -$4.23M 0.58% 76
2020
Q3
$36M Sell
204,432
-12,167
-6% -$1.95M 0.74% 60
2020
Q2
$33.2M Sell
216,599
-5,570
-3% -$848K 0.72% 65
2020
Q1
$31.1M Buy
+222,169
New +$33.2M 0.88% 50

Other funds holding STE

Geneva Capital Management's STE Position: Q2 2026 in Review

Geneva Capital Management reduced its Steris (STE) stake by 5% in Q2 2026, selling an estimated $1.16M and leaving 103,634 shares worth $21.8M. The position accounts for 0.5% of the portfolio, ranked #57.

Geneva Capital Management first reported a position in STE in Q1 2020 and has held it in 26 quarters since. The position peaked at $36.5M in Q4 2021. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Geneva Capital Management held 103,634 shares of Steris worth $21.8M as of Q2 2026.
  • Geneva Capital Management sold 5,417 Steris shares in Q2 2026, an estimated $1.16M.
  • Steris made up 0.5% of Geneva Capital Management's portfolio in Q2 2026, its #57 holding.
  • Geneva Capital Management first reported a position in Steris in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's Steris position peaked at $36.5M in Q4 2021.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.